Screener
Sana Biotechnology SANA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from employee stock purchase plan and exercise of stock options | 59 | 1,127 |
| Fees related to common stock financings, net | (96) | (60) |
| Principal payments, net for tenant improvement loan | (91) | (85) |
| Net cash provided by (used in) financing activities | (128) | 982 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 11,930 | (31,072) |
| Cash, cash equivalents, and restricted cash at beginning of period | 76,065 | 131,398 |
| Cash, cash equivalents, and restricted cash at end of period | $87,995 | $100,326 |
| SUPPLEMENTAL CASH FLOW INFORMATION: |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's financing cash flow?
- Sana Biotechnology (SANA) reported financing cash flow of -$128K in Q1 2026.
- How has Sana Biotechnology's financing cash flow changed year-over-year?
- Sana Biotechnology's financing cash flow decreased by 113.0% year-over-year, from $982K to -$128K.
- What is the long-term trend for Sana Biotechnology's financing cash flow?
- Over 4 years (2021 to 2025), Sana Biotechnology's financing cash flow has grown at a -32.8% compound annual growth rate (CAGR), from $631.75M to $128.73M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Sana Biotechnology's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude